ELV · NASDAQ · STOCK
Elevance Health
$394.22
52W $274.84 – $436.24
59/100
$85.49B
17.5
0.68
Is ELV Bullish or Bearish?
Bullish.
Innellis AI committee rates Elevance Health (ELV) Buy with a composite score of 59/100
, based on 6 analysts with 50% agreement.
Last updated August 08, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +16.36 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -3.64 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull & Bear Case
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.47 across 28 articles, 14d) — News
Bear Case
- EPS declining -4.2% YoY despite any revenue growth — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- Current ratio of 0.19 is tight -- limited short-term liquidity cushion — Risk
- Bollinger bandwidth of 16.0% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 08, 2026
Overall Committee Score
59/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 56%
of 95 Healthcare peers
Value Analyst
neutral
58
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
Growth Analyst
neutral
44
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ 4 consecutive earnings beats -- consistent execution
− EPS declining -4.2% YoY despite any revenue growth
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ MACD histogram positive -- bullish momentum
Risk Analyst
neutral
47
/ 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
− Current ratio of 0.19 is tight -- limited short-term liquidity cushion
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
73
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.47 across 28 articles, 14d)
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 4 existing position pair(s) are highly correlated already
Investment Thesis Evolution
Committee score moved marginally from 58.6 to 58.6.
- New bearish signals: 1 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- News Analyst: +1 bullish signal(s).
- Risk Analyst: +1 bearish signal(s).
Comparing 2026-08-07 to 2026-08-08 (1 day apart).
Technical Analysis
RSI (14)
60.3
Neutral
MACD Histogram
1.393
Bullish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Hh Hl
Support
$392.45
Resistance
$399.79
Bollinger %B
0.61
Inside Bands
Price vs Moving Averages
EMA 9
$386.49
Above
EMA 21
$388.24
Above
EMA 50
$387.62
Above
EMA 200
$365.41
Above
Fundamental Analysis
Valuation
95
Growth
59
Profitability
43
Financial Health
75
Cash Flow
70
Valuation
P/E Ratio
17.5×
P/B Ratio
1.91×
PEG Ratio
-3.89
Dividend Yield
1.74%
52W High
$436.24
52W Low
$274.84
Quality & Growth
ROE
1290.3%
ROA
466.0%
Gross Margin
3895.2%
Operating Margin
351.1%
Revenue Growth YoY
—
Debt / Equity
0.69
AI Fundamental Assessment
P/E ratio of 17.5 (inexpensive relative to a 15-40x range); Price-to-book of 1.9x; PEG ratio of -3.9 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 12.9%; Return on assets of 4.7%; Net margin of 2.5%; Gross margin of 39.0%; Current ratio of 1.52 (tight short-term liquidity); Debt-to-equity of 0.69; Free cash flow per share is positive (28.86); Most recent quarter beat estimates by 18.9%; 4 consecutive earnings beats; EPS growth decelerating (+277.8% -> -40.8% QoQ); Average YoY EPS growth of -15.7%; Analyst estimates rising over recent quarters
Get the Full ELV Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →